| 1 | Relaxin-3 and receptors in the human and rhesus brain and reproductive tissues. (Silvertown JD, Neschadim A, Liu HN, Shannon P, Walia JS, Kao JC, Robertson J, Summerlee AJ, Medin JA) Regul Pept 2010 Jan 08;159(1-3):44-53 24 Citations |
| 1 | Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. (Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, Wigley FM, Moreland LW, Silver R, Kim YH, Steen VD, Firestein GS, Kavanaugh AF, Weisman M, Mayes MD, Collier D, Csuka ME, Simms R, Merkel PA, Medsger TA Jr, Sanders ME, Maranian P, Seibold JR, Relaxin Investigators and the Scleroderma Clinical Trials Consortium) Arthritis Rheum 2009 Apr;60(4):1102-11 125 Citations |
| 1 | Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth. (Silvertown JD, Symes JC, Neschadim A, Nonaka T, Kao JC, Summerlee AJ, Medin JA) FASEB J 2007 Mar;21(3):754-65 53 Citations |
| 1 | Functional expression of mouse relaxin and mouse relaxin-3 in the lung from an Ebola virus glycoprotein-pseudotyped lentivirus via tracheal delivery. (Silvertown JD, Walia JS, Summerlee AJ, Medin JA) Endocrinology 2006 Aug;147(8):3797-808 25 Citations |
| 1 | H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. (Silvertown JD, Ng J, Sato T, Summerlee AJ, Medin JA) Int J Cancer 2006 Jan 01;118(1):62-73 78 Citations |
| 1 | Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. (Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier D, Wigley FM, Merkel PA, Csuka ME, Hsu V, Rocco S, Erikson M, Hannigan J, Harkonen WS, Sanders ME) Ann Intern Med 2000 Jun 06;132(11):871-9 248 Citations |
